SARAH BUCHANAN: Open Payments
NPI 1245503366 · ERWIN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,461 in 68 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,461
Food & beverage: $1,461
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $266 |
| Lundbeck LLC | 10 | $220 |
| AstraZeneca Pharmaceuticals LP | 8 | $190 |
| Vanda Pharmaceuticals Inc. | 3 | $123 |
| Lilly USA, LLC | 6 | $106 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $98 |
| Otsuka America Pharmaceutical, Inc. | 5 | $93 |
| ABBVIE INC. | 4 | $74 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $58 |
| Xeris Pharmaceuticals, Inc. | 3 | $54 |
Products named: REXULTI, Ozempic, FANAPT, MOUNJARO, AIRSUPRA, CAPLYTA, BREZTRI, Kerendia.
Industry payments across TN — which companies pay providers there.
